Connect with us

National

China’s pledge may hurt Zimbabwe’s coal plans

Published

on

BY JEVANS NYABIAGE

If there is a country likely to be hurt the most by President Xi Jinping’s decision for Beijing to stop building new power plants overseas, it is Zimbabwe.

Advertisement

Among several African countries with large deposits of coal, it is heavily dependent on China after it had sanctions imposed on it by the United States and some European countries because of former president Robert Mugabe’s human rights abuses and policy of seizing land from white farmers.

It was planning to build several coal-fired power plants costing a total of US$15 billion, with Chinese lenders initially committed to them.

Private funding was not forthcoming, partly because of growing opposition from environmental campaigners.

Advertisement

But on Tuesday, in a pre-recorded speech to the United Nations General Assembly, Xi sounded a death knell for several coal projects, including in Zimbabwe, for which Chinese lenders were expected to provide financing.

The southern African nation’s demand for power exceeds its supply, causing it to seek to build more plants.

Its electricity shortage means it cannot attract power-intensive manufacturing companies.

Advertisement

Xi’s pledge could halt dozens of coal power projects in Africa, although there had already been a notable slowdown in new financing since Xi last year announced a target for net-zero emissions by 2060.

China is the single largest financier of coal-powered plants overseas as well as the largest producer and consumer of coal.

But Beijing has not funded any coal projects abroad in the first half of this year and the country’s largest financier of such projects, Industrial and Commercial Bank of China, said it would start phasing out coal from its portfolio.

Advertisement

The bank in July declined to fund the US$3 billion Sengwa coal project, in Zimbabwe’s north, as pressure grew from activists and communities.

Independent climate change think tank E3G says Zimbabwe is among the laggards – also including Botswana and Mozambique – who continue to pursue coal-fired plants, bucking the global trend of retiring or not funding the environmentally destructive energy source.

The Zimbabwean government has been vocal in its continued pursuit of new coal, even as Chinese financiers pull out, E3G said in its latest report about the collapse of the global coal pipeline.

Advertisement

The country has 990 megawatts of coal power plants under construction and 4.5GW in the pipeline, but the Chinese government’s freeze on funding them is likely to force it to seek alternative sources of financing or shift to solar and hydro power.

Besides Zimbabwe, Botswana and Mozambique, other countries that may be forced by China’s pivot to stall their coal plant plans include Kenya, Djibouti, Madagascar, Malawi and South Africa.

Xi’s statement means “existing and agreed projects will be honoured but new projects will be off the table”, according to Yun Sun, director of the China programme at the Stimson ­Centre in Washington. Groundwork, an environmental justice organisation working in South Africa, welcomed Xi’s statement, calling it a victory for the thousands of community activists in countries including Zimbabwe, Kenya, Ghana, Senegal, Ivory Coast and South Africa who had “challenged their governments and China, and said no to coal”. “We challenge President Xi to end support from all Chinese institutions … that keep Africa’s coal mines, plants and other infrastructure under construction or planned,” Groundwork said.
Lauri Myllyvirta, the lead analyst at the Centre for Research on Energy and Clean Air, said the announcement signalled a major policy shift for China and “leaves no international financing for new coal”.

Advertisement

“Making any new financing or equity investment commitments to coal power projects overseas would be toxic for any Chinese bank or power company,” Myllyvirta said.
“For projects that haven’t yet achieved financial close, that’s likely to be the end of the story.”

However, Myllyvirta said it was not yet clear what forms of involvement in coal power projects had been ruled out, and where the line would be drawn for projects that were already initiated. According to Boston University Global Development Policy Centre, the Chinese state has funded coal projects worth US$43 billion since 2000, mainly in Asia and southern Africa. “Now that the world’s major governments have led by example and banned overseas coal plants, it is time for the private sector, which finances 87 per cent of overseas coal, to follow suit,” said Kevin Gallagher, the centre’s director. “We will not meet our global climate and development goals if the private sector continues to finance overseas coal.”
Christoph Nedopil Wang, the founding director of the Green Belt and Road Initiative Centre, said Chinese financial institutions and engineering companies had historically been an important source of financing and engineering capacity for overseas coal development.

“The door has been shut to [governments] in coal-rich countries to ask for Chinese financing and engineering in new coal projects,” Wang said. But he said there was not yet clarity on whether the announcement would halt already announced coal-fired projects. Rishikesh Ram Bhandary, a climate finance and international climate negotiations expert, said China’s decision was “likely to bolster the voices calling for a greater focus on renewables within these countries”. However, he said it was unlikely to have an immediate impact on South Africa and Zimbabwe. “As our database shows, the coal-fired power plants funded by the Chinese policy bank are already under construction or in operation,” he said.
“Of course, we need further details from the Chinese government to fully understand what the announcement includes and excludes.

Advertisement

“With the last source of major public finance for coal-fired power plants being removed, countries such as South Africa and Zimbabwe will need to think carefully about the policies they need, and the infrastructure required to significantly scale up renewables.” – China Morning Post

Advertisement
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

National

Tragic attack in Madlambuzi: Five dead as suspected mental patient goes on rampage

Published

on

BY WANDILE TSHUMA 

Police in Madlambuzi, Matabeleland South Province has are a suspected mental patient, Phamani Sibanda, following a violent rampage that left five people dead and two others injured on Wednesday.

According to the police statement, Sibanda (43) allegedly attacked seven people in the village using a Mopani log, a blunt object, and an unknown sharp weapon, targeting anyone who crossed his path.

The victims of this tragic attack have been identified by their next of kin:

Elliot Khupe, 101, a male adult from Bellas Village
Butho Tshuma, 97, a female adult from Bellas Village
Constance Sibanda, 66, a female adult from Bellas Village
Tiffan Surprise Ndlovu, 6, a female juvenile from Bellas Village
Catra Matsika, 72, from Central Village

In addition to the fatalities, two other women, aged 90 and 41, sustained injuries and are currently receiving treatment at Madlambuzi Clinic and Plumtree District Hospital.

The ZRP has underscored the pressing need for community awareness regarding mental health issues. “We implore the public to promptly refer mental patients to medical institutions for treatment and to actively monitor their behavior to prevent such violent incidents,” the statement elaborated. It encouraged community members to report any concerns to the National Complaints Desk at (0242) 703631 or via WhatsApp at 0712 800197, or to approach the nearest police station.

 

Continue Reading

National

US suspends visa processing in Zimbabwe, embassy says

Published

on

BY REUTERS

The United States has stopped processing most visas in Zimbabwe until further notice, its embassy in the capital Harare said on Wednesday, citing unspecified concerns with the government.
“We have paused routine visa services in Harare while we address concerns with the Government of Zimbabwe,” the embassy said in a post on X. It said the move was not a travel ban and that current visas would remain valid.
The government of the Southern African country did not immediately reply to a request for comment.
The pause took effect on August 7, according to a notice on the U.S. State Department’s website, which said it applied to all visa services with the exception of most diplomatic and official visas.
U.S. President Donald Trump’s administration has restricted travel from a number of African countries, saying it is working to prevent visa overstaying and misuse.
Zimbabwe had a visa overstay rate of 10.57% in 2023, according to a U.S. Department of Homeland Security report.
Starting this week, the U.S. will require visa applicants from Zambia and Malawi to pay bonds of up to $15,000 for some visitor visas. The Trump administration has also paused visa processing in Niger.
Harare resident Angella Chirombo said her 18-year-old son had received a scholarship to do his bachelor’s degree at Michigan State University and had been waiting for a visa interview when the pause hit.
“He was supposed to be in school already. I paid for everything else and was waiting for the visa so I could buy tickets,” she told Reuters.
She said other parents were considering booking interviews at other U.S. embassies in Southern Africa, but that she wouldn’t be able to afford the travel.
“Now they are saying we can go to Zambia and Namibia. I don’t even have money right now and I don’t know where to get this money. They are so many students that have been affected.”

Continue Reading

National

Landmark HIV trial begins in Zimbabwe

Published

on


BY PAUL SIXPENCE

ZIMBABWE became the first site for the administration of a new investigational HIV vaccine. The first doses of the IAVI C114 clinical trial were administered in late July 2025 at the Mutala Trust clinical site in Harare, CITE reports.
“This is a landmark moment for South Africa, Zimbabwe, and the continent. It shows the power of true partnership,” said Dr. Tariro Makadzange, clinical trial lead, Mutala Trust.

“We are edging closer to an HIV vaccine, made possible by global collaboration, with clinical trials conducted in Africa, for Africa, and for the world.”

The development of the vaccine is a partnership that brings together Zimbabwe’s Mutala Trust, ReiThera, the Ragon Institute, International AIDS Vaccine Initiative (IAVI) and African researchers who are co-leading every phase of the trial.

In phase one of the trial, the vaccine candidate, Gorilla Adenovirus Vectored HIV Networked Epitopes Vaccine (GRAdHIVNE1) will be administered to 120 adults between the ages of 18 and 50 years including 48 people living with HIV who are virally suppressed on antiretroviral therapy (ART). Besides Zimbabwe, two other clinical trial sites are located in Cape Town and Durban, South Africa.

Trial sites were chosen on the basis of their high HIV burden and to ensure that the vaccine candidate is tested within communities affected by the epidemic.

This phase of the trial will assess the safety and ability of the vaccine candidate to provoke an immune response in the human body in persons living with HIV and those who are HIV negative.

“The IAVI C114 trial is testing a new vaccine candidate known as GRAdHIVNE1. The trial represents the first time this vaccine is being tested in humans and is aimed at assessing the safety of the vaccine and its ability to stimulate the immune system,” said Dr. Vincent Muturi-Kioi, HIV Vaccines Product Development Team Lead, IAVI.

In a statement, IAVI further advised that “trial participants will receive either one or two doses of the investigational vaccine or a placebo and will be monitored over a period of 19 months for safety and immune responses.” Results of the trial are likely to be available in 2027.

In the past, several HIV vaccine trials have been conducted but none proved effective in preventing HIV acquisition. The novelity of this vaccine candidate lies in that, it uses a harmless viral vector to deliver small parts of HIV “derived from critical structural regions of HIV that are less likely to mutate” with an expected likelihood to trigger an immune response.

“GRAdHIVNE1 uses a harmless virus (a vector for the vaccine derived from a non-replicating gorilla adenovirus) to deliver small, conserved parts of HIV (called epitopes) to the body’s immune system. These targets are derived from critical structural regions of HIV that are less likely to mutate, making them good targets for killer T cells in the immune system (CD8+ T cell responses) — a type of immune defense thought to be important for long-term protection against HIV. The viral vector was selected based on its ability to stimulate this type of response. Should the vaccine be successful in stimulating the desired response, it could be tested in future trials to assess its efficacy,” Dr. Vincent Muturi-Kioi further explained.

The initiation of this clinical trial demonstrates the power of partnerships at a time when the world is witnessing funding cuts towards global public health research. The IAVIC114 clinical trial is sponsored by IAVI. The vaccine candidate, GRAdHIVNE1, was developed by ReiThera and the Ragon Institute with funding from the GatesFoundation. African researchers will be leading

SOURCE| CITE

Advertisement



Continue Reading

Trending

Copyright © 2022 VicFallsLive. All rights reserved, powered by Advantage